-
Teva Stock Soars 26%!
Teva Pharmaceuticals
Teva Pharmaceuticals' stock surged 26% after the TL1A antibody duvakitug demonstrated strong efficacy in treating ulcerative colitis (UC) and Crohn's disease (CD). The Phase 2b RELIEVE study showed promising results, with duvakitug outperforming existing treatments.
科尔|
抚远县|
额尔古纳市|
都匀市|
通许县|
江华|
泰安市|
乐都县|
临颍县|
南投县|
保康县|
轮台县|
睢宁县|
临泽县|
乌拉特中旗|
洛隆县|
阳曲县|
宝丰县|
富源县|
晋城|
浙江省|
钟祥市|
越西县|
都安|
西乌珠穆沁旗|
乡城县|
石景山区|
仪征市|
高州市|
西充县|
洛隆县|
施甸县|
吉隆县|
乌鲁木齐市|
涿州市|
突泉县|
平顺县|
涞水县|
莎车县|
革吉县|
平武县|